About Gilead Sciences

Gilead Sciences is a leading biopharmaceutical company dedicated to creating a healthier world for all people. For over 35 years, Gilead has pioneered therapies for some of the world's most challenging diseases, including HIV, viral hepatitis, COVID-19, and cancer. With a relentless focus on innovation, Gilead develops life-changing scientific advancements that improve patient outcomes and ensure global access to cutting-edge treatments. The company's work in oncology, particularly through its Kite Pharma subsidiary, has revolutionized cell therapy with CAR-T treatments, offering hope to patients with hard-to-treat cancers. Gilead also advances solutions in inflammatory diseases, solidifying its position as a leader in life sciences. Headquartered in the U.S., Gilead maintains a strong global presence, including in Brazil, where it continues to expand its impact.

Role Overview

The Market Access Lead – Cell Therapy position at Gilead Sciences in Sao Paulo, Brazil, represents an exciting opportunity within the expanding Brazil Market Access team. Reporting to the Associate Director of Market Access, this full-time role is based in the Sao Paulo office and focuses on driving reimbursement and access for CAR-T therapies. You will develop and execute pricing strategies, craft value propositions backed by clinical and economic evidence, and collaborate across functions to shape the access landscape for private markets and hospitals. This role offers flexibility and growth potential as Gilead's portfolio evolves, allowing you to contribute directly to patient access in oncology.

Key Responsibilities

In this pivotal role, you will lead efforts to secure CAR-T reimbursement by developing strategies tailored to payer archetypes and regional needs. Key responsibilities include contributing to pricing strategies aligned with brand objectives, supporting Key Account Managers with field guidance, and partnering with Medical teams on evidence generation for HTA and reimbursement gaps. You will prepare and submit reimbursement dossiers, monitor access KPIs, manage the Market Access budget, and build cross-functional relationships to foster win-win partnerships. Additionally, ensuring compliance with Gilead's Business Conduct Manual and external regulations is paramount, alongside leveraging market intelligence for key account segmentation.

Strategic Collaboration

Work closely with internal stakeholders to anticipate payer environment changes and provide input for brand planning. Train teams on payer-relevant materials, including value stories and tools, to enable effective access solutions benefiting patients and Gilead therapies.

Qualifications & Requirements

The ideal candidate brings robust, demonstrable experience in developing and delivering market access and health economic strategies. A solid understanding of Market Access processes, payer strategies at national, regional, and local levels, and pricing dynamics impacting biopharma portfolios like Gilead's Kite therapies is essential. You should demonstrate accountability, the ability to navigate uncertainty, and a sense of urgency for time-sensitive issues. Strong networking skills to build credible relationships with internal colleagues and external payers, combined with excellent teamwork and facilitation abilities, are critical. Experience in cell therapy or oncology market access is highly advantageous.

Benefits & Perks

Gilead Sciences offers a comprehensive benefits package designed to support your professional and personal well-being. Enjoy competitive compensation with a salary buffer reflecting biopharmaceutical sector rates in Sao Paulo, performance-based incentives, and opportunities for bonuses. Health insurance, retirement plans, and wellness programs are standard. The flexible organization provides professional development, training on cutting-edge payer tools, and exposure to an evolving product portfolio. Work in a collaborative environment where every employee is empowered, with access to Gilead's global resources and a focus on work-life balance in the vibrant Sao Paulo office.

Career Growth

This role offers substantial growth potential within Gilead's dynamic structure. As the Brazil Market Access team expands, your scope may broaden to encompass new therapies in HIV, oncology, and inflammatory diseases. Gilead invests in employee development through leadership training, cross-functional projects, and mentorship from experienced People Leaders. Ambitious professionals can advance to director-level positions, contributing to global strategies while making a tangible impact on patient lives. The company's culture emphasizes inclusion, empowerment, and bold ambitions, positioning you for long-term success.

Why Join Gilead

Joining Gilead means becoming part of a mission-driven team tackling humanity's biggest health challenges. In Brazil, you'll play a key role in ensuring access to innovative CAR-T therapies, directly influencing patient outcomes in oncology. Gilead's commitment to collaboration, determination, and scientific innovation creates an environment where passionate individuals thrive. With a focus on employee experience, great leadership, and inclusive culture, Gilead empowers you to fulfill your aspirations while advancing therapies for HIV, cancer, viral hepatitis, and inflammatory diseases. Make a difference at a company where every role drives bold ambitions forward.

Role FAQs

What is the reporting structure?

This position reports to the Associate Director of Market Access in the Sao Paulo office.

Is travel required?

Some field support for Key Account Managers may involve regional travel within Brazil.

What experience level is needed?

Robust experience in market access, health economics, and payer strategies is required, ideally in biopharma or cell therapy.

Does Gilead support professional development?

Yes, through training, cross-functional collaboration, and opportunities tied to portfolio expansion.

How does this role impact patients?

By securing reimbursement and access, you enable more patients to benefit from Gilead's life-changing CAR-T therapies.